Last reviewed · How we verify
Bupivacaine-Dexamethasone
Bupivacaine-Dexamethasone is a Small molecule drug developed by SEBASTIAN ROCHE. It is currently FDA-approved.
Bupivacaine-Dexamethasone, marketed by Sebastian Roche, is a combination drug currently available in the market with a key composition patent expiring in 2028. The drug's key strength lies in its unique mechanism of combining bupivacaine and dexamethasone, potentially offering enhanced efficacy and duration of action compared to monotherapy options. The primary risk is the patent expiry in 2028, which could lead to increased competition from generic alternatives.
At a glance
| Generic name | Bupivacaine-Dexamethasone |
|---|---|
| Sponsor | SEBASTIAN ROCHE |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Arthrosemid vs. Steroid for the Management Knee Osteoarthritis (PHASE4)
- Comparison of Intrathecal Morphine and Rectus Sheath Block for Postoperative Pain Management After Lower Abdominal Surgery With Midline Incision (NA)
- Comparison Between Dexamethasone and Dexmedetomidine in Spinal Anesthesia for Cases With Fracture Pelvis Fixation (EARLY_PHASE1)
- Postoperative Pain Monitoring With ANI in Lumbar Spine Surgery (NA)
- Pericapsular Nerve Group Block Versus Intrathecal Morphine for Analgesia After Total Hip Arthroplasty (NA)
- Thoracic Epidural Analgesia With Bilateral Erector Spinae Plane Block in Radical Cystectomy Surgery (NA)
- ESP Block VS Intrathecal Opioid After Laparoscopic Colorectal Surgery (PHASE1, PHASE2)
- Prospective Evaluation of Efficacy of Tumescent Steroid Infiltration in Mandibular Third Molar Surgery: a Split Mouth Randomized Study (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Bupivacaine-Dexamethasone CI brief — competitive landscape report
- Bupivacaine-Dexamethasone updates RSS · CI watch RSS
- SEBASTIAN ROCHE portfolio CI
Frequently asked questions about Bupivacaine-Dexamethasone
What is Bupivacaine-Dexamethasone?
Who makes Bupivacaine-Dexamethasone?
What development phase is Bupivacaine-Dexamethasone in?
Related
- Manufacturer: SEBASTIAN ROCHE — full pipeline
- Compare: Bupivacaine-Dexamethasone vs similar drugs
- Pricing: Bupivacaine-Dexamethasone cost, discount & access